Expression of matrix metalloproteinases and endogenous inhibitors within ascending aortic aneurysms of patients with bicuspid or tricuspid aortic valves

Objective The mechanisms contributing to ascending thoracic aortic aneurysms associated with bicuspid aortic valves may differ from ascending thoracic aortic aneurysms with tricuspid aortic valves. Matrix metalloproteinases and their endogenous inhibitors have been causally linked to ascending thora...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of thoracic and cardiovascular surgery 2007-04, Vol.133 (4), p.1028-1036
Main Authors: Ikonomidis, John S., MD, PhD, Jones, Jeffery A., PhD, Barbour, John R., MD, Stroud, Robert E., MS, Clark, Leslie L., MS, Kaplan, Brooke S., BS, Zeeshan, Ahmed, MD, Bavaria, Joseph E., MD, Gorman, Joseph H., MD, Spinale, Francis G., MD, PhD, Gorman, Robert C., MD
Format: Article
Language:English
Subjects:
Adult
Aged
Aged, 80 and over
Aortic Aneurysm - complications
Aortic Aneurysm - metabolism
Aortic Aneurysm - surgery
Aortic Valve
Cardiothoracic Surgery
Cardiovascular Surgical Procedures
Female
Heart Valve Diseases - complications
Heart Valve Diseases - physiopathology
Heart Valve Diseases - surgery
Humans
Male
Matrix Metalloproteinases - biosynthesis
Middle Aged
Tissue Inhibitor of Metalloproteinases - biosynthesis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective The mechanisms contributing to ascending thoracic aortic aneurysms associated with bicuspid aortic valves may differ from ascending thoracic aortic aneurysms with tricuspid aortic valves. Matrix metalloproteinases and their endogenous inhibitors have been causally linked to ascending thoracic aortic aneurysm formation. This study tested the hypothesis that specific and different matrix metalloproteinase and tissue inhibitors of metalloproteinase profiles would be observed in ascending thoracic aortic aneurysm samples from patients with bicuspid aortic valves versus tricuspid aortic valves. Methods Ascending thoracic aortic aneurysm samples taken from patients with bicuspid aortic valve (n = 53) and patients with tricuspid aortic valve (n = 46) were assessed for representative subtypes of all matrix metalloproteinase classes and all 4 known tissue inhibitors of metalloproteinases. Levels were compared [optical density units, median (interquartile range)] both to reference control ascending aortic samples (n = 26) and within each valve group by aneurysm diameter (≤3.9 cm, 4.0-5.9 cm and ≥6.0 cm). Results Different and specific matrix metalloproteinase and tissue inhibitors of metalloproteinase profiles were observed in the ascending thoracic aortic aneurysm groups. In bicuspid aortic valves, matrix metalloproteinase-2 increased by 34% when compared with either tricuspid aortic valves or control ( P < .05), and matrix metalloproteinase-14 decreased by 59% compared with tricuspid aortic valves ( P < .05). In tricuspid aortic valve samples, tissue inhibitors of metalloproteinase-2 decreased by 35% when compared with either tricuspid aortic valves or control ( P < .05), and matrix metalloproteinase-13 increased by 140% in the 4.0- to 5.9-cm diameter range ( P < .05). Conclusions A unique matrix metalloproteinase and tissue inhibitor of metalloproteinase portfolio was observed in ascending thoracic aortic aneurysms from patients with bicuspid aortic valve compared with patients with tricuspid aortic valve. These differences, suggesting disparate mechanisms of extracellular matrix remodeling, may provide unique biochemical targets for ascending thoracic aortic aneurysm prognostication and treatment in these 2 groups of patients.
ISSN:0022-5223
1097-685X
DOI:10.1016/j.jtcvs.2006.10.083